Haemophilus influenzae type b vaccine impact in resource-poor settings in Asia and Africa (Q33394304)

26 July 2017

1 reference

title

Haemophilus influenzae type b vaccine impact in resource-poor settings in Asia and Africa (English)

1 reference

26 July 2017

1 reference

Haemophilus influenzae

object named as

Haemophilus influenzae

1 reference

1

Bradford D Gessner

1 reference

26 July 2017

1 January 2009

1 reference

Expert Review of Vaccines

26 July 2017

1 reference

26 July 2017

8

1 reference

26 July 2017

1

1 reference

26 July 2017

91-102

1 reference

Decline of Childhood Haemophilus influenzae Type b (Hib) Disease in the Hib Vaccine Era

26 July 2017

1 reference

https://api.crossref.org/works/10.1586%2F14760584.8.1.91

The UK Hib vaccine experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.8.1.91

Randomised trial of Haemophilus influenzae type-b tetanus protein conjugate vaccine [corrected] for prevention of pneumonia and meningitis in Gambian infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.8.1.91

Elimination of Haemophilus influenzae type b (Hib) disease from The Gambia after the introduction of routine immunisation with a Hib conjugate vaccine: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.8.1.91

Effectiveness of Haemophilus influenzae type b Conjugate vaccine introduction into routine childhood immunization in Kenya

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.8.1.91

Impact of haemophilus influenzae type b conjugate vaccine in South Africa and Argentina

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.8.1.91

Impact of conjugate Haemophilus influenzae type b (Hib) vaccine introduction in South Africa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.8.1.91

Reduced effectiveness of Haemophilus influenzae type b conjugate vaccine in children with a high prevalence of human immunodeficiency virus type 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.8.1.91

Action for child survival: elimination of Haemophilus influenzae type b meningitis in Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.8.1.91

Haemophilus influenzae type b conjugate vaccine is highly effective in the Ugandan routine immunization program: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.8.1.91

The impact of routine infant immunization with Haemophilus influenzae type b conjugate vaccine in Malawi, a country with high human immunodeficiency virus prevalence

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.8.1.91

Introduction of Haemophilus influenzae type B conjugate vaccine into routine immunization in Ghana and its impact on bacterial meningitis in children younger than five years

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.8.1.91

Incidences of vaccine-preventable Haemophilus influenzae type b pneumonia and meningitis in Indonesian children: hamlet-randomised vaccine-probe trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.8.1.91

Effectiveness of Haemophilus influenzae type B conjugate vaccine on prevention of pneumonia and meningitis in Bangladeshi children: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.8.1.91

Immunogenicity and effectiveness of Haemophilus influenzae type b conjugate vaccine in HIV infected and uninfected African children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.8.1.91

Catch-up vaccination against Haemophilus influenzae type b in human immunodeficiency virus-infected Thai children older than 2 years old.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.8.1.91

Vaccination with a Haemophilus influenzae type b conjugate vaccine reduces oropharyngeal carriage of H. influenzae type b among Gambian children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.8.1.91

Economic evaluation of delivering Haemophilus influenzae type b vaccine in routine immunization services in Kenya

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.8.1.91

Cost-benefit analysis of a Haemophilus influenzae type b meningitis prevention programme in The Philippines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.8.1.91

Vaccine-preventable haemophilus influenza type B disease burden and cost-effectiveness of infant vaccination in Indonesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.8.1.91

Re-emergence of Haemophilus influenzae type b (Hib) disease in The Gambia following successful elimination with conjugate Hib vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.8.1.91

Worldwide variation in the incidence of Haemophilus influenzae type b meningitis and its association with ampicillin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.8.1.91

Effectiveness of Haemophilus influenzae b conjugate vaccine on childhood pneumonia: a case-control study in Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.8.1.91

Case fatality proportions and predictive factors for mortality among children hospitalized with severe pneumonia in a rural developing country setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.8.1.91

World Health Organisation definition of "radiologically-confirmed pneumonia" may under-estimate the true public health value of conjugate pneumococcal vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.8.1.91

The impact of vaccines on pneumonia: key lessons from Haemophilus influenzae type b conjugate vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.8.1.91

Response of human immunodeficiency virus-exposed and -infected infants to Haemophilus influenzae type b conjugate vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.8.1.91

The immunogenicity of Haemophilus influenzae type b conjugate vaccines in children born to human immunodeficiency virus-infected women. Women and Infants Transmission Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.8.1.91

The Alaska Haemophilus influenzae type b experience: lessons in controlling a vaccine-preventable disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.8.1.91

Prevention ofHaemophilus influenzaeType b (Hib) Meningitis and Emergence of Serotype Replacement with Type a Strains after Introduction of Hib Immunization in Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.8.1.91

Outbreak of invasive Haemophilus influenzae serotype a disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.8.1.91

Haemophilus influenzae invasive disease in the United States, 1994-1995: near disappearance of a vaccine-preventable childhood disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.8.1.91

Economic evaluation of general childhood vaccination against Haemophilus influenzae type b in Sweden.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.8.1.91

21 January 2018

Identifiers

DOI

10.1586/14760584.8.1.91

1 reference

26 July 2017

1 reference

PubMed ID

19093776